Literature DB >> 31061088

Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.

Jae Young Lee1,2, Min Joung Kim1, Speros Thomas1, Viola Oorschot3, Georg Ramm4, Pei Mun Aui1, Yuichi Sekine5, Devy Deliyanti6, Jennifer Wilkinson-Berka6, Be'eri Niego7, Alan R Harvey8,9, Paschalis Theotokis10, Catriona McLean11, Stephen M Strittmatter5, Steven Petratos12.   

Abstract

We previously identified that ngr1 allele deletion limits the severity of experimental autoimmune encephalomyelitis (EAE) by preserving axonal integrity. However, whether this favorable outcome observed in EAE is a consequence of an abrogated neuronal-specific pathophysiological mechanism, is yet to be defined. Here we show that, Cre-loxP-mediated neuron-specific deletion of ngr1 preserved axonal integrity, whereas its re-expression in ngr1-/- female mice potentiated EAE-axonopathy. As a corollary, myelin integrity was preserved under Cre deletion in ngr1flx/flx , retinal ganglion cell axons whereas, significant demyelination occurred in the ngr1-/- optic nerves following the re-introduction of NgR1. Moreover, Cre-loxP-mediated axon-specific deletion of ngr1 in ngr1flx/flx mice also demonstrated efficient anterograde transport of fluorescently-labeled ChTxβ in the optic nerves of EAE-induced mice. However, the anterograde transport of ChTxβ displayed accumulation in optic nerve degenerative axons of EAE-induced ngr1-/- mice, when NgR1 was reintroduced but was shown to be transported efficiently in the contralateral non- recombinant adeno-associated virus serotype 2-transduced optic nerves of these mutant mice. We further identified that the interaction between the axonal motor protein, Kinesin-1 and collapsin response mediator protein 2 (CRMP2) was unchanged upon Cre deletion of ngr1 Whereas, this Kinesin-1/CRMP2 association was reduced when NgR1 was re-expressed in the ngr1-/- optic nerves. Our data suggest that NgR1 governs axonal degeneration in the context of inflammatory-mediated demyelination through the phosphorylation of CRMP2 by stalling axonal vesicular transport. Moreover, axon-specific deletion of ngr1 preserves axonal transport mechanisms, blunting the induction of inflammatory demyelination and limiting the severity of EAE.SIGNIFICANCE STATEMENT Multiple sclerosis (MS) is commonly induced by aberrant immune-mediated destruction of the protective sheath of nerve fibers (known as myelin). However, it has been shown that MS lesions do not only consist of this disease pattern, exhibiting heterogeneity with continual destruction of axons. Here we investigate how neuronal NgR1 can drive inflammatory-mediated axonal degeneration and demyelination within the optic nerve by analyzing its downstream signaling events that govern axonal vesicular transport. We identify that abrogating the NgR1/pCRMP2 signaling cascade can maintain Kinesin-1-dependent anterograde axonal transport to limit inflammatory-mediated axonopathy and demyelination. The ability to differentiate between primary and secondary mechanisms of axonal degeneration may uncover therapeutic strategies to limit axonal damage and progressive MS.
Copyright © 2019 the authors.

Entities:  

Keywords:  Kinesin-1; Nogo receptor 1; axonal degeneration; collapsin response mediator protein 2; demyelination; experimental autoimmune encephalomyelitis

Mesh:

Substances:

Year:  2019        PMID: 31061088      PMCID: PMC6616297          DOI: 10.1523/JNEUROSCI.1760-18.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  50 in total

1.  Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP.

Authors:  A Kamal; A Almenar-Queralt; J F LeBlanc; E A Roberts; L S Goldstein
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

2.  Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.

Authors:  M Onuki; M M Ayers; C C Bernard; J M Orian
Journal:  Microsc Res Tech       Date:  2001-03-15       Impact factor: 2.769

3.  Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.

Authors:  Gorazd B Stokin; Concepción Lillo; Tomás L Falzone; Richard G Brusch; Edward Rockenstein; Stephanie L Mount; Rema Raman; Peter Davies; Eliezer Masliah; David S Williams; Lawrence S B Goldstein
Journal:  Science       Date:  2005-02-25       Impact factor: 47.728

4.  GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity.

Authors:  Takeshi Yoshimura; Yoji Kawano; Nariko Arimura; Saeko Kawabata; Akira Kikuchi; Kozo Kaibuchi
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

5.  Axonal loss in normal-appearing white matter in a patient with acute MS.

Authors:  C Bjartmar; R P Kinkel; G Kidd; R A Rudick; B D Trapp
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

6.  Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.

Authors:  Ji-Eun Kim; Betty P Liu; James H Park; Stephen M Strittmatter
Journal:  Neuron       Date:  2004-10-28       Impact factor: 17.173

7.  Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis.

Authors:  N Evangelou; D Konz; M M Esiri; S Smith; J Palace; P M Matthews
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

8.  Rho kinase inhibition enhances axonal regeneration in the injured CNS.

Authors:  Alyson E Fournier; Bayan T Takizawa; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2003-02-15       Impact factor: 6.167

9.  Early glial responses in murine models of multiple sclerosis.

Authors:  Margaret M Ayers; Lisa J Hazelwood; Deanne V Catmull; Dongwei Wang; Quinn McKormack; Claude C A Bernard; Jacqueline M Orian
Journal:  Neurochem Int       Date:  2004 Jul-Aug       Impact factor: 3.921

10.  The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.

Authors:  Tara Karnezis; Wim Mandemakers; Jonathan L McQualter; Binhai Zheng; Peggy P Ho; Kelly A Jordan; Belinda M Murray; Ben Barres; Marc Tessier-Lavigne; Claude C A Bernard
Journal:  Nat Neurosci       Date:  2004-06-06       Impact factor: 24.884

View more
  4 in total

1.  Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models.

Authors:  Seiko Ikezu; Kaitlin L Ingraham Dixie; Lacin Koro; Takashi Watanabe; Kozo Kaibuchi; Tsuneya Ikezu
Journal:  Acta Neuropathol Commun       Date:  2020-02-04       Impact factor: 7.801

2.  B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF.

Authors:  Maha M Bakhuraysah; Paschalis Theotokis; Jae Young Lee; Amani A Alrehaili; Pei-Mun Aui; William A Figgett; Michael F Azari; John-Paul Abou-Afech; Fabienne Mackay; Christopher Siatskas; Frank Alderuccio; Stephen M Strittmatter; Nikolaos Grigoriadis; Steven Petratos
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.996

Review 3.  Use of Gene Therapy in Retinal Ganglion Cell Neuroprotection: Current Concepts and Future Directions.

Authors:  Jess Rhee; Kendrick Co Shih
Journal:  Biomolecules       Date:  2021-04-15

4.  Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis.

Authors:  Aubin Moutal; Sergey Kalinin; Kathy Kowal; Natalia Marangoni; Jeffrey Dupree; Shao Xia Lin; Kinga Lis; Lucia Lisi; Kenneth Hensley; Rajesh Khanna; Douglas L Feinstein
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.